A detailed history of Abbrea Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Abbrea Capital, LLC holds 32,999 shares of ABT stock, worth $4.25 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
32,999
Previous 33,720 2.14%
Holding current value
$4.25 Million
Previous $3.83 Million 10.54%
% of portfolio
0.45%
Previous 0.5%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $72,626 - $81,069
-721 Reduced 2.14%
32,999 $3.43 Million
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $19,166 - $21,168
175 Added 0.52%
33,720 $3.83 Million
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $27,507 - $33,672
-305 Reduced 0.9%
33,545 $3.69 Million
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $3,343 - $4,011
35 Added 0.1%
33,850 $3.28 Million
Q2 2023

Aug 01, 2023

BUY
$100.78 - $112.29 $56,537 - $62,994
561 Added 1.69%
33,815 $3.69 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $55,500 - $65,327
573 Added 1.75%
33,254 $3.37 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $39,830 - $46,726
-419 Reduced 1.27%
32,681 $3.59 Million
Q3 2022

Nov 03, 2022

SELL
$96.76 - $112.03 $40,929 - $47,388
-423 Reduced 1.26%
33,100 $3.2 Million
Q2 2022

Aug 02, 2022

SELL
$102.07 - $123.37 $18,168 - $21,959
-178 Reduced 0.53%
33,523 $3.64 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $15,392 - $18,770
135 Added 0.4%
33,701 $3.99 Million
Q4 2021

Feb 04, 2022

BUY
$115.53 - $141.46 $97,160 - $118,967
841 Added 2.57%
33,566 $4.72 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $11,082 - $12,260
-95 Reduced 0.29%
32,725 $3.87 Million
Q2 2021

Aug 04, 2021

BUY
$105.79 - $124.53 $148,106 - $174,342
1,400 Added 4.46%
32,820 $3.81 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $19,373 - $22,824
-178 Reduced 0.56%
31,420 $3.77 Million
Q4 2020

Jan 21, 2021

BUY
$105.0 - $114.42 $48,930 - $53,319
466 Added 1.5%
31,598 $3.46 Million
Q3 2020

Oct 20, 2020

SELL
$91.64 - $111.29 $65,980 - $80,128
-720 Reduced 2.26%
31,132 $3.39 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $8,192 - $10,486
107 Added 0.34%
31,852 $2.91 Million
Q1 2020

Apr 29, 2020

SELL
$62.82 - $91.86 $691 - $1,010
-11 Reduced 0.03%
31,745 $2.51 Million
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $38,862 - $43,263
-495 Reduced 1.53%
31,756 $2.76 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $281,529 - $305,265
3,440 Added 11.94%
32,251 $2.7 Million
Q2 2019

Jul 31, 2019

SELL
$72.88 - $85.0 $21,135 - $24,650
-290 Reduced 1.0%
28,811 $2.42 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $6,555 - $7,925
-99 Reduced 0.34%
29,101 $2.33 Million
Q4 2018

Feb 05, 2019

BUY
$65.56 - $74.27 $37,697 - $42,705
575 Added 2.01%
29,200 $2.11 Million
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $39,222 - $47,317
645 Added 2.31%
28,625 $2.1 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $23,891 - $26,369
415 Added 1.51%
27,980 $1.71 Million
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $61,278 - $69,282
1,089 Added 4.11%
27,565 $1.65 Million
Q4 2017

Feb 01, 2018

BUY
$53.68 - $57.47 $41,870 - $44,826
780 Added 3.04%
26,476 $1.51 Million
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $1.23 Million - $1.38 Million
25,696
25,696 $1.37 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.